COFCO Biotechnology Co., Ltd. Class A

COFCO Biotechnology Co., Ltd. Class A

SSZSE:000930
4.76
CNY
-0.02
(-0.42%)
7.89BMarket Cap
Oct 24Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7.67
7.51
6.69
5.81
8.55
9.53
10.54
10.77
12.78
10.73
11.07
10.77
9.45
- -
Basic EPS, GAAP
0.05
0.04
-1.47
0.13
0.5
0.26
0.32
0.32
0.61
0.57
-0.33
0.01
0.02
- -
Free Cash Flow per Basic Share
0.52
0.08
-0.21
0.65
0.46
-0.96
1.49
-2.11
2.02
0.08
0.72
-0.18
0.63
- -
Dividend per Share
0.19
0.17
0.19
0.14
0.42
0.1
0.11
0.09
0.15
0.3
0.64
0.05
0.04
0.04
Book Value per Share
2.98
3
1.49
1.62
5.78
5.02
5.33
5.57
6.11
6.49
5.6
5.66
5.72
5.55
Tangible Book Value per Share
2.61
2.64
1.13
1.27
4.45
4.33
4.69
4.92
5.57
5.96
5.09
5.14
5.18
5.03
Basic Weighted Avg Shares
957
952
965
964
1,859
1,858
1,847
1,848
1,844
1,857
1,842
1,861
1,854
1,857
Sales/Revenue/Turnover
7,340
7,153
6,457
5,603
15,892
17,704
19,472
19,909
23,560
19,918
20,379
20,053
17,512
- -
Operating Margin (%)
0.69
1.2
-9.49
2.95
7.83
7.82
8.25
6.14
7.93
8.53
0.6
2.88
2.82
- -
Depreciation Expense
257
272
276
168
613
609
425
436
450
458
492
507
517
- -
Net Income, GAAP
51
35
-1,418
127
929
483
593
593
1,130
1,059
-602
25
38
- -
Effective Tax Rate (%)
6.78
47.11
- -
1.95
13.59
16.26
16.13
21.67
18
22.01
- -
64.68
44.01
- -
Profit Margin (%)
0.69
0.49
-21.96
2.27
5.85
2.73
3.04
2.98
4.79
5.31
-2.95
0.13
0.22
- -
Working Capital
-962
-819
-1,150
-1,113
-4,444
-398
219
570
2,046
2,509
894
973
1,101
1,530
LT Debt
779
688
564
378
535
646
275
311
524
297
362
342
526
1,453
Total Equity
3,093
3,104
1,574
1,706
5,957
9,694
10,228
10,802
11,755
12,510
10,854
10,916
11,015
10,701
Return on Invested Capital (%)
-2.27
-0.52
- -
-1.78
11.96
3.99
3.84
4.06
6.82
6.79
- -
0.17
-0.02
- -
Return on Capital (%)
3.28
2.01
- -
6.22
13.8
4.57
5.31
4.08
7.65
7.28
- -
0.28
0.55
- -
Return on Common Equity (%)
1.78
1.22
-65.58
8.48
26.07
6.51
6.2
5.86
10.37
9.01
-5.34
0.24
0.36
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,907
2,565
3,461
LT Borrowings
368
509
1,299
LT Finance Leases
158
160
154
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,856
1,856
1,856
Market Capitalization
10,712
12,531
7,890

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
6,120
6,997
7,212
Cash, Cash Equivalents & STI
2,488
1,817
2,129
Accounts Receivable, Net
823
1,229
1,223
Inventories
1,886
2,780
2,348
Total Current Liabilities
5,019
5,981
5,682
Payables & Accruals
- -
- -
- -
ST Debt
1,907
2,565
3,461
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.49%
0.7%
0.9%
Free Cash Flow
-123.33%
-9.46%
-458.34%
Net Income, GAAP
37.29%
-24.84%
52.68%
Sales/Revenue/Turnover
18.49%
-1.82%
-12.67%
Total Cash Common Dividend
55.13%
35.38%
-11.14%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,732
5,179
5,213
4,929
20,053
2025
4,385
4,427
- -
4,250
17,512
2026
3,879
4,315
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.02
-0.03
0.01
0.01
2025
0.02
0.04
- -
-0.02
0.02
2026
-0.07
-0.03
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.05
2025
0.01
0.01
- -
0.01
0.04
2026
0.01
0.02
- -
- -
- -

Company Description

CEO
De Guo Zhang
Full Time Employees
4,832
Sector
Process industries
Industry
Chemicals: specialty
Address
Building A Bengbu China 100020
IPO Date
Jul 12, 1999
Business
COFCO Biotechnology Co., Ltd. (000930.SZ) engages in corn deep processing and biotechnology innovation, producing food ingredients, bioenergy, and biodegradable materials from high-quality corn sourced from Northeast China's Golden Corn Belt. The company offers starch, modified starch, glucose syrup, monosodium glutamate, citric acid, fuel ethanol, edible alcohol, alcohol disinfectant solution, polylactic acid, vitamin E, phytosterol, lactide, PHA, and D-allulose; it operates through food ingredients, bioenergy, and biomass materials segments. COFCO Biotechnology maintains over 20 subsidiaries across Heilongjiang, Jilin, Tianjin, Hebei, Anhui, Shanghai, Hubei, Sichuan, Guangxi, and Thailand, serving domestic and international markets with a processing capacity of around 7 million tons of corn annually. Founded in 1998 and headquartered in Bengbu, Anhui Province, China, the company, a subsidiary of COFCO Group, listed on the Shenzhen Stock Exchange in 1999 and changed its name from COFCO Biochemical (Anhui) Co., Ltd. in September 2019. COFCO Biotechnology recently launches D-allulose products in September 2025 for food applications including beverages, dairy, and baking; establishes a new biotechnology subsidiary, Anhui COFCO Biotechnology Co., Ltd., with 250 million yuan registered capital for bio-based materials research, polymerization, and manufacturing; and approves construction of starch sugar and allulose production facilities as of December 2025.